Sonus Pharmaceuticals, Inc (SNUS)
Sonus Pharmaceuticals, Inc. engages in the development of oncology drugs for the treatment of cancer by utilizing its TOCOSOL technology primarily in the United States. Its TOCOSOL technology uses vitamin E oil and tocopherol derivatives to create, solubilize, and stabilize drugs. Its primary product candidate TOCOSOL Paclitaxel is an injectable paclitaxel emulsion for the treatment cancers. The company also develops SN2310 Injectable Emulsion, a camptothecin derivative. Sonus Pharmaceuticals has collaboration and license agreement with Schering AG, pursuant to which Schering has a worldwide exclusive license to market and promote TOCOSOL Paclitaxel and is responsible for clinical...
read more
QUOTE
As of 08:23PM EDT May 26, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
SNUS |
| SIC: |
-
|
| State location: |
WA |
| Sector: |
- |
| State of Inc: |
DE |
| Employees: |
43 |
| Type: |
NASDAQ |
SONUS PHARMACEUTICALS, INC (SNUS) MESSAGE BOARD
